{
  "frames":[
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-2-1",
      "text":"NBI-31772, a small molecule that inhibits the binding of IGF-1 to IGFBPs",
      "arguments":[
        {
          "text":"binding of IGF-1 to IGFBPs",
          "argument-type":"event",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"evem-PMC546277-UAZ-r1-546277-2-2"
        },
        {
          "text":"NBI-31772",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-2-3"
        }
      ],
      "type":"regulation",
      "frame-type":"event-mention",
      "subtype":"negative-regulation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":468,
        "object-type":"relative-pos"
      },
      "trigger":"inhibits",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":396,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-2",
      "found-by":"Negative_regulation_syntax_5_verb",
      "verbose-text":"We studied the effect of NBI-31772, a small molecule that inhibits the binding of IGF-1 to IGFBPs, on the restoration of proteoglycan synthesis by human OA chondrocytes."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-2-2",
      "text":"binding of IGF-1 to IGFBPs",
      "arguments":[
        {
          "text":"IGF-1",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-2-1"
        },
        {
          "text":"IGFBPs",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":1,
          "arg":"ment-PMC546277-UAZ-r1-546277-2-2"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":468,
        "object-type":"relative-pos"
      },
      "trigger":"binding",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":442,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-2",
      "found-by":"binding_token_4",
      "verbose-text":"We studied the effect of NBI-31772, a small molecule that inhibits the binding of IGF-1 to IGFBPs, on the restoration of proteoglycan synthesis by human OA chondrocytes."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-12-11",
      "text":"IGF-1/IGFBP interaction",
      "arguments":[
        {
          "text":"IGF-1",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-12-51"
        },
        {
          "text":"IGFBP",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":1,
          "arg":"ment-PMC546277-UAZ-r1-546277-12-52"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":1750,
        "object-type":"relative-pos"
      },
      "trigger":"interaction",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":1727,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-12",
      "found-by":"binding7a",
      "context":[
        "cntx-PMC546277-UAZ-r1-546277-0-1"
      ],
      "verbose-text":"This study shows that a new pharmacological approach that uses a small molecule inhibiting IGF-1 and IGFBP interaction could restore or potentiate proteoglycan synthesis in OA chondrocytes, thereby opening exciting possibilities for the treatment of OA and, potentially, of other joint related diseases."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-15-9",
      "text":"IGF-1 stimulates the linear growth of bones by increasing the proliferation",
      "arguments":[
        {
          "text":"proliferation",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-15-64"
        },
        {
          "text":"IGF-1",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-15-62"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":2299,
        "object-type":"relative-pos"
      },
      "trigger":"stimulates",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":2224,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-15",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"During postnatal, childhood, and pubertal life, IGF-1 stimulates the linear growth of bones by increasing the proliferation of epiphyseal chondrocytes and remodeling processes within the growth plate cartilage [XREF_BIBR, XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-30-17",
      "text":"IGFBP-3 synthesized by OA",
      "arguments":[
        {
          "text":"IGFBP-3",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-30-129"
        },
        {
          "text":"OA",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-30-130"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":4860,
        "object-type":"relative-pos"
      },
      "trigger":"synthesized",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":4835,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-30",
      "found-by":"Positive_activation_syntax_2_verb",
      "verbose-text":"The expression of IGFBP-3 was 24 times as high in human OA chondrocytes as in normal chondrocytes [XREF_BIBR], and the amount of IGFBP-3 synthesized by OA cartilage was three times that in normal cartilage [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-35-6",
      "text":"IGFBP-3 blocked the effects of IGF-1 [",
      "arguments":[
        {
          "text":"IGF-1 [",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-35-153"
        },
        {
          "text":"IGFBP-3",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-35-152"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":5856,
        "object-type":"relative-pos"
      },
      "trigger":"blocked",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":5818,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-35",
      "found-by":"Negative_activation_syntax_1_verb",
      "verbose-text":"Additionally, anabolic responses of chondrocytes to IGF-1 were dependent on the level of secreted IGFBPs, and the addition of IGFBP-3 blocked the effects of IGF-1 [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-37-16",
      "text":"interaction between IGF and IGFBP",
      "arguments":[
        {
          "text":"IGF",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-37-159"
        },
        {
          "text":"IGFBP",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":1,
          "arg":"ment-PMC546277-UAZ-r1-546277-37-160"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":6231,
        "object-type":"relative-pos"
      },
      "trigger":"interaction",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":6198,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-37",
      "found-by":"binding11_token",
      "context":[
        "cntx-PMC546277-UAZ-r1-546277-0-1"
      ],
      "verbose-text":"In this study, a nonpeptide small molecule previously described as a potent inhibitor of interaction between IGF and IGFBP [XREF_BIBR] was used as a potential tool to restore the anabolic response of OA chondrocytes to IGF-1."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-67-15",
      "text":"NBI-31772 either restored or augmented IGF-1-dependent anabolism",
      "arguments":[
        {
          "text":"anabolism",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-67-242"
        },
        {
          "text":"NBI-31772",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-67-241"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"positive-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":10638,
        "object-type":"relative-pos"
      },
      "trigger":"augmented",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":10574,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-67",
      "found-by":"Positive_activation_syntax_1_verb",
      "verbose-text":"These results suggest that NBI-31772 either restored or augmented IGF-1-dependent anabolism in human OA chondrocytes by disrupting the interaction of the growth factor with its endogenous IGFBPs."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-72-4",
      "text":"interaction between IGF-1 and IGFBP",
      "arguments":[
        {
          "text":"IGF-1",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-72-260"
        },
        {
          "text":"IGFBP",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":1,
          "arg":"ment-PMC546277-UAZ-r1-546277-72-261"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":11792,
        "object-type":"relative-pos"
      },
      "trigger":"interaction",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":11757,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-72",
      "found-by":"binding11",
      "context":[
        "cntx-PMC546277-UAZ-r1-546277-54-20"
      ],
      "verbose-text":"This experiment definitely ruled out the possibility that NBI-31772 may act independently of its ability to inhibit the interaction between IGF-1 and IGFBP."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-86-18",
      "text":"IGF-1 was primarily bound to IGFBPs",
      "arguments":[
        {
          "text":"IGF-1",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-86-311"
        },
        {
          "text":"IGFBPs",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":1,
          "arg":"ment-PMC546277-UAZ-r1-546277-86-312"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":14009,
        "object-type":"relative-pos"
      },
      "trigger":"bound",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":13974,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-86",
      "found-by":"binding_17",
      "context":[
        "cntx-PMC546277-UAZ-r1-546277-1-2"
      ],
      "verbose-text":"By contrast with IGF-1, R 3 IGF-1 did not compete with 125 I labeled IGF-1, demonstrating that IGF-1 was primarily bound to IGFBPs within cartilage."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-90-3",
      "text":"NBI-31772, a small, nonpeptide compound that binds to endogenous IGFBPs and releases biologically active IGF-1",
      "arguments":[
        {
          "text":"NBI-31772",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-90-322"
        },
        {
          "text":"IGF-1",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":1,
          "arg":"ment-PMC546277-UAZ-r1-546277-90-323"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":14504,
        "object-type":"relative-pos"
      },
      "trigger":"binds",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":14394,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-90",
      "found-by":"binding_17",
      "context":[
        "cntx-PMC546277-UAZ-r1-546277-0-1"
      ],
      "verbose-text":"The results of the present study show that NBI-31772, a small, nonpeptide compound that binds to endogenous IGFBPs and releases biologically active IGF-1 [XREF_BIBR], can restore proteoglycan synthesis by human OA chondrocytes, therefore opening the possibility of a new field of pharmacological intervention for the treatment of OA and other joint related diseases."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-100-7",
      "text":"IGFBP-3 inhibition of Balb",
      "arguments":[
        {
          "text":"Balb",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-100-370"
        },
        {
          "text":"IGFBP-3",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-100-369"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":16415,
        "object-type":"relative-pos"
      },
      "trigger":"inhibition",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":16389,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-100",
      "found-by":"Negative_activation_syntax_3_noun",
      "verbose-text":"This discrepancy was also found in a previous study reporting the activity of NBI-31772 on the reversal of IGFBP-3 inhibition of Balb and c3T3 IGF-1-dependent proliferation [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-100-8",
      "text":"IGFBP-3 inhibition of Balb/c3T3",
      "arguments":[
        {
          "text":"c3T3",
          "argument-type":"entity",
          "type":"controlled",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-100-371"
        },
        {
          "text":"IGFBP-3",
          "argument-type":"entity",
          "type":"controller",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-100-369"
        }
      ],
      "type":"activation",
      "frame-type":"event-mention",
      "subtype":"negative-activation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":16420,
        "object-type":"relative-pos"
      },
      "trigger":"inhibition",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":16389,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-100",
      "found-by":"Negative_activation_syntax_3_noun",
      "verbose-text":"This discrepancy was also found in a previous study reporting the activity of NBI-31772 on the reversal of IGFBP-3 inhibition of Balb and c3T3 IGF-1-dependent proliferation [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-108-10",
      "text":"IGF-1/IGFBP complexes",
      "arguments":[
        {
          "text":"IGF-1",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-108-389"
        },
        {
          "text":"IGFBP",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":1,
          "arg":"ment-PMC546277-UAZ-r1-546277-108-390"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":17544,
        "object-type":"relative-pos"
      },
      "trigger":"complexes",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":17523,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-108",
      "found-by":"binding_complex_A_B",
      "context":[
        "cntx-PMC546277-UAZ-r1-546277-54-20"
      ],
      "verbose-text":"NBI-31772 also significantly increased the ratio of cell associated proteoglycans in the presence of IGF-1 and IGFBP complexes."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-112-14",
      "text":"IGF-1/IGFBP complexes",
      "arguments":[
        {
          "text":"IGF-1",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-112-400"
        },
        {
          "text":"IGFBP",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":1,
          "arg":"ment-PMC546277-UAZ-r1-546277-112-401"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":18289,
        "object-type":"relative-pos"
      },
      "trigger":"complexes",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":18268,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-112",
      "found-by":"binding_complex_A_B",
      "context":[
        "cntx-PMC546277-UAZ-r1-546277-109-26"
      ],
      "verbose-text":"Under physiological conditions, IGF-1 and IGFBP complexes can be disrupted by various proteases [XREF_BIBR], thereby releasing active IGF-1."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-113-12",
      "text":"phosphorylate the IGF-1 receptor",
      "arguments":[
        {
          "text":"IGF-1 receptor",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-113-406"
        }
      ],
      "type":"protein-modification",
      "frame-type":"event-mention",
      "subtype":"phosphorylation",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":18562,
        "object-type":"relative-pos"
      },
      "trigger":"phosphorylate",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":18530,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-113",
      "found-by":"Phosphorylation_syntax_1a_verb",
      "context":[
        "cntx-PMC546277-UAZ-r1-546277-109-26"
      ],
      "verbose-text":"In a recent report by Fowlkes and co-workers, matrix metalloproteinase 3 was able to disrupt IGF and IGFBP -3 complexes and to liberate free, intact IGFs able to phosphorylate the IGF-1 receptor and to trigger cell proliferation [XREF_BIBR]."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-128-5",
      "text":"IGF/IGFBP interaction",
      "arguments":[
        {
          "text":"IGF",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-128-443"
        },
        {
          "text":"IGFBP",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":1,
          "arg":"ment-PMC546277-UAZ-r1-546277-128-444"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":21496,
        "object-type":"relative-pos"
      },
      "trigger":"interaction",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":21475,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-128",
      "found-by":"binding7a",
      "context":[
        "cntx-PMC546277-UAZ-r1-546277-128-28"
      ],
      "verbose-text":"In view of a therapeutic application, the optimization of small chemical inhibitors of IGF and IGFBP interaction would be preferred over the use of IGF-1 peptide mutants (either binding receptors and triggering biological effects without binding IGFBPs, or, conversely, displacing endogenous IGF-1 from IGFBPs without binding receptors), since the former should be more easily optimizable while the latter should be more susceptible to the attack by proteases."
    },
    {
      "frame-id":"evem-PMC546277-UAZ-r1-546277-132-13",
      "text":"IGF/IGFBP interaction",
      "arguments":[
        {
          "text":"IGF",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":0,
          "arg":"ment-PMC546277-UAZ-r1-546277-132-451"
        },
        {
          "text":"IGFBP",
          "argument-type":"entity",
          "type":"theme",
          "object-type":"argument",
          "index":1,
          "arg":"ment-PMC546277-UAZ-r1-546277-132-452"
        }
      ],
      "type":"complex-assembly",
      "frame-type":"event-mention",
      "is-direct":false,
      "end-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":22305,
        "object-type":"relative-pos"
      },
      "trigger":"interaction",
      "object-type":"frame",
      "start-pos":{
        "reference":"pass-PMC546277-UAZ-r1-546277",
        "offset":22284,
        "object-type":"relative-pos"
      },
      "sentence":"sent-PMC546277-UAZ-r1-546277-132",
      "found-by":"binding7a",
      "context":[
        "cntx-PMC546277-UAZ-r1-546277-19-8"
      ],
      "verbose-text":"A small, nonpeptide pharmacological inhibitor of IGF and IGFBP interaction restored or enhanced the IGF-1-dependent proteoglycan synthesis by human osteoarthritic chondrocytes."
    }
  ],
  "object-type":"frame-collection",
  "object-meta":{
    "processing-end":"2016-09-11T16:48:08Z",
    "doc-id":"PMC546277",
    "component-type":"machine",
    "component":"Reach",
    "processing-start":"2016-09-11T16:45:58Z",
    "object-type":"meta-info",
    "organization":"UAZ"
  }
}
